"Denali Therapeutics Announces FDA Clinical Hold on DNL919 Investigational New Drug (IND) Application" - ATV:TREM2 is an antibody designed to modulate TREM2 - https://t.co/6rLiYypNEn & https://t.co/QcdKaLnWdm & https://t.co/xTYEPpDLPi https://t.co/
755 followers
1,900 followers
New insights into the role of TREM2 in Alzheimer’s disease | Molecular Neurodegeneration | Full Text https://t.co/aOQH9xuILY
982 followers
11,124 followers
A new publication from ANA president Dr. David Holtzman summarizes new insight into the involvement of TREM2 and microglia in Alzheimer's disease development that may open new therapeutic strategies @BioMedCentral https://t.co/LWIY9zbzrK